Subtype
Endometrial Neoplasm
CI-CAN-00007648Explore in graph →
Non-malignant400 active trials4 approved drugs28 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00007648Explore in graph →
Clinical trials
1,340 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00375804 | Racial Disparity in Endometrial Cancer | terminated | — | 43 | University of LouisvilleOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT00820898 | Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 24 | Gynecologic Oncology GroupNETWORK | 1 | Dec 29, 2017 | clinicaltrials |
| NCT00258362 |
| Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer |
| completed |
| Phase 2 |
| 41 |
| Masonic Cancer Center, University of MinnesotaOTHER |
| 1 |
| Dec 28, 2017 |
| clinicaltrials |
| NCT00381888 | Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer | completed | Phase 2 | 44 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00610740 | CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer | completed | Phase 2 | 18 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 28, 2017 | clinicaltrials |
| NCT00888173 | Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 45 | Gynecologic Oncology GroupNETWORK | 1 | Dec 6, 2017 | clinicaltrials |
| NCT00287885 | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | completed | Phase 1 | 18 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Nov 29, 2017 | clinicaltrials |
| NCT01582906 | A Survivorship Care Plan for Gynaecological Cancer Patients | completed | — | 150 | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 24, 2017 | clinicaltrials |
| NCT00070317 | Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer | terminated | N/A | 102 | Gynecologic Oncology GroupNETWORK | 1 | Nov 6, 2017 | clinicaltrials |
| NCT01853865 | Follow-up of Endometrial Cancer Patients(OPAL) | unknown | N/A | 211 | Odense University HospitalOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT03330015 | Patient's Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal Bleeding | completed | — | 206 | Chinese University of Hong KongOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT01225887 | Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 37 | Gynecologic Oncology GroupNETWORK | 1 | Oct 9, 2017 | clinicaltrials |
| NCT02135562 | Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors | completed | N/A | 11 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 20, 2017 | clinicaltrials |
| NCT00508703 | Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy | completed | — | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 12, 2017 | clinicaltrials |
| NCT01256268 | Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids | completed | Phase 1 | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 30, 2017 | clinicaltrials |
| NCT00039442 | Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer | completed | Phase 2 | 21 | Gynecologic Oncology GroupNETWORK | 1 | Aug 24, 2017 | clinicaltrials |
| NCT00460356 | Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes | completed | — | 159 | Gynecologic Oncology GroupNETWORK | 1 | Aug 24, 2017 | clinicaltrials |
| NCT00575952 | Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer | completed | Phase 1 | 27 | Gynecologic Oncology GroupNETWORK | 1 | Aug 24, 2017 | clinicaltrials |
| NCT01208467 | Prognostic Biomarkers in Patients With Endometrial Cancer | completed | — | 2,824 | Gynecologic Oncology GroupNETWORK | 1 | Aug 23, 2017 | clinicaltrials |
| NCT02852954 | Progesterone Induced Blocking Factor Expression Levels in Endometrial Cancer Cells. | completed | — | 60 | Kayseri Education and Research HospitalOTHER_GOV | 0 | Aug 18, 2017 | clinicaltrials |
| NCT03171506 | Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification | completed | N/A | 57 | University of Alabama at BirminghamOTHER | 0 | Aug 10, 2017 | clinicaltrials |
| NCT00017004 | Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | completed | Phase 3 | 114 | Gynecologic Oncology GroupNETWORK | 1 | Aug 9, 2017 | clinicaltrials |
| NCT01641497 | Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer(TOMOGYN) | terminated | N/A | 26 | Centre Oscar LambretOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT01922778 | Screening for Endometrial Abnormalities in Overweight and Obese Women | completed | N/A | 303 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT01914276 | Lymphedema in Endometrial Cancer | completed | — | 100 | Duke UniversityOTHER | 1 | Jun 23, 2017 | clinicaltrials |
| NCT02684318 | Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 100 | Poveda, Andrés, M.D.INDIV | 1 | Jun 22, 2017 | clinicaltrials |
| NCT01184053 | Trisenox® in Women With Metastatic Endometrial Cancer(NRR) | terminated | Phase 2 | 3 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT01205672 | Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer | completed | Early Phase 1 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 2, 2017 | clinicaltrials |
| NCT01461746 | Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer | unknown | Phase 2 | 67 | Asan Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT01461759 | Efficacy Study of Chemotherapy to Treat Advanced or Recurrent Endometrial Cancer | unknown | Phase 2 | 59 | Asan Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT01679483 | Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer | completed | N/A | 40 | Asan Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00997373 | Letrozole as a Treatment of Endometrial Cancer | completed | N/A | 43 | University of California, DavisOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00879359 | Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer | completed | Phase 2 | 15 | The Cleveland ClinicOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT02543710 | Biomarker Guided Treatment in Gynaecological Cancer(Momatec2) | recruiting | Phase 4 | 1,300 | Haukeland University HospitalOTHER | 3 | Mar 28, 2017 | clinicaltrials |
| NCT01444456 | Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia | completed | — | 1,262 | AmgenINDUSTRY | 9 | Mar 20, 2017 | clinicaltrials |
| NCT00545792 | Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers | completed | Phase 2 | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 15, 2017 | clinicaltrials |
| NCT00883116 | A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer(IXAMPLE2) | terminated | Phase 3 | 551 | R-PharmINDUSTRY | 19 | Mar 9, 2017 | clinicaltrials |
| NCT02262455 | Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors | completed | Phase 1 | 32 | Santa Maria BiotherapeuticsINDUSTRY | 1 | Feb 13, 2017 | clinicaltrials |
| NCT02064725 | Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA | unknown | Phase 2 | 8 | Kevelt ASINDUSTRY | 5 | Jan 24, 2017 | clinicaltrials |
| NCT03005015 | Lenvatinib in Second Line Endometrial Carcinoma | withdrawn | Phase 2 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Dec 29, 2016 | clinicaltrials |
| NCT00448643 | Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery | completed | Phase 1 | 12 | University of MiamiOTHER | 1 | Dec 15, 2016 | clinicaltrials |
| NCT02990728 | Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer | unknown | Phase 2 | 120 | Chang Gung Memorial HospitalOTHER | 0 | Dec 13, 2016 | clinicaltrials |
| NCT02987777 | Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer | completed | — | 80 | Institut de Cancérologie de LorraineOTHER | 0 | Dec 9, 2016 | clinicaltrials |
| NCT00171808 | Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer(deFEND) | completed | Phase 2 | 26 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT01562106 | Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery | completed | N/A | 123 | Swedish Medical CenterOTHER | 1 | Nov 18, 2016 | clinicaltrials |
| NCT02943811 | Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer | completed | — | 951 | Università degli Studi dell'InsubriaOTHER | 0 | Nov 15, 2016 | clinicaltrials |
| NCT01216813 | Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer | completed | — | 33 | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 1, 2016 | clinicaltrials |
| NCT00897442 | Collecting Tumor Samples From Patients With Gynecological Tumors | completed | — | 275 | Gynecologic Oncology GroupNETWORK | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02017353 | Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma | completed | Phase 2 | 7 | University Hospital, GasthuisbergOTHER | 1 | Oct 25, 2016 | clinicaltrials |
| NCT02560571 | Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients | unknown | Phase 2 | 200 | Meir Medical CenterOTHER | 1 | Sep 20, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jan 9, 2018source: clinicaltrials